| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 187.46▲ | 187.29▲ | 187.21▲ | 187.10▲ | 183.84▲ |
| MA10 | 187.36▲ | 187.35▲ | 186.55▲ | 185.16▲ | 188.06▼ |
| MA20 | 187.51▼ | 186.69▲ | 187.89▼ | 185.77▲ | 182.34▲ |
| MA50 | 187.36▲ | 188.31▼ | 186.03▲ | 185.18▲ | 154.88▲ |
| MA100 | 187.03▲ | 185.87▲ | 185.56▲ | 179.27▲ | 166.49▲ |
| MA200 | 188.07▼ | 185.83▲ | 187.59▼ | 158.47▲ | 210.61▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.107▲ | -0.115▼ | 0.192▲ | -1.338▼ |
| RSI | 50.871▲ | 50.595▲ | 51.551▲ | 51.629▲ | 58.506▲ |
| STOCH | 40.855 | 31.529 | 59.948 | 57.338 | 53.047 |
| WILL %R | -64.286 | -37.226 | -42.215 | -43.681 | -35.557 |
| CCI | 26.398 | 3.848 | 35.104 | 69.355 | 37.149 |
|
Monday, March 30, 2026 10:07 AM
The US Food and Drug Administration has approved a higher-dose version of Spinraza, a key therapy from Biogen Inc (NASDAQ:BIIB, XETRA:IDP) for spinal muscular atrophy (SMA), a move analysts at ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/03/26 | 186.02 | 190.09 | 185.895 | 187.46 | 607,225 |
| 27/03/26 | 191.06 | 191.06 | 183.045 | 183.84 | 935,069 |
| 26/03/26 | 189.00 | 192.275 | 188.355 | 191.06 | 879,045 |
| 25/03/26 | 184.91 | 189.38 | 184.91 | 189.18 | 775,200 |
| 24/03/26 | 182.63 | 184.84 | 180.33 | 183.94 | 636,241 |
| 23/03/26 | 183.48 | 185.00 | 183.02 | 183.64 | 911,799 |
| 20/03/26 | 183.13 | 183.6905 | 180.48 | 181.46 | 1,560,674 |
| 19/03/26 | 182.18 | 185.445 | 181.68 | 183.41 | 727,343 |
| 18/03/26 | 184.13 | 184.32 | 180.48 | 182.31 | 846,200 |
| 17/03/26 | 184.73 | 186.52 | 183.20 | 185.29 | 810,200 |
|
|
||||
|
|
||||
|
|